cytarabine solution for injection or infusion
accord healthcare limited - cytarabine - solution for injection or infusion - 100mg/ml
cytarabine solution for injection or infusion
accord healthcare limited - cytarabine - solution for injection or infusion - 100mg/ml
v-tabur
vitamed pharmaceutical industries ltd - alcohol 70 %; chlorhexidine gluconate - solution - external - alcohol 70 % 70 %v/v; chlorhexidine gluconate 0.5 %w/v - chlorhexidine - chlorhexidine - disinfection of the skin, and for the cleaning of babies umbillical cords until detached.
polysept ointment
rekah pharmaceutical industry ltd, israel - povidone-iodine - ointment - povidone-iodine 10 % - povidone-iodine - povidone-iodine - for the disinfection of skin infections and inflammations, wounds and superficial burns.
polysept solution
rekah pharmaceutical industry ltd, israel - povidone-iodine - solution - povidone-iodine 10 % - povidone-iodine - povidone-iodine - antiseptic for use in first aid in wounds, scratches, mild burns. for treatment of skin infections caused by bacteria or fungi.
v-crima
vitamed pharmaceutical industries ltd - hydroxyethylcellulose; povidone - solution - povidone 1.65 %; hydroxyethylcellulose 0.4 % - other ophthalmologicals - artificial tears.
cytarabine
accord healthcare limited - cytarabine - solution for inj/inf - 100 mg/ml - cytarabine
terazosin 5mg tablets
accord healthcare limited - terazosin - tablet - 5 milligram(s) - alpha-adrenoreceptor antagonists; terazosin
terazosin 2mg tablets
accord healthcare limited - terazosin - tablet - 2 milligram(s) - alpha-adrenoreceptor antagonists; terazosin
xalkori 200 mg hard capsules
pfizer limited - crizotinib - hard capsules - 200 mg - carcinoma, non-small-cell lung - anti-neoplastic agents, protein kinase inhibitor - indicated for the treatment of adults with previously treated anaplastic lymphoma kinase (alk)-positive advanced non-small cell lung cancer (nsclc)